The Pharma Data

NOVEMBER 9, 2020

Image: Copyright © 2009-2020 Merck Sharp & Dohme Corp., It is very clear that in this study, the addition of ipilimumab did not add clinical benefit but did add toxicity. a subsidiary of Merck & Co., Kenilworth, N.J., All rights reserved. Merck , also known as MSD outside of the U.S.

Research Laboratories 52

Research Laboratories Laboratories Treatment Therapies 52

Drug Target Review

SEPTEMBER 26, 2023

1-4 This approach saves time, money, and resources, and ultimately leads to safer medicines going forward to the clinic. CNS-related issues account for nearly a quarter of failures during clinical development, a phase where consequences are high in terms of resources and patient impact. 2009 Sep;14(17–18):876–84.

Drugs 111

Drugs FDA Disease Animal Testing 111

Conversations in Drug Development Trends

FEBRUARY 22, 2023

I completed a few long-distance rides and raised some funds for research, and in the process, I realized this is what I wanted to do with the rest of my life. I joined the FARA staff in 2009, and our team built a nationwide series of bike rides called rideATAXIA to raise funds for research. So, I decided to pivot.

Disease 52

Disease Clinical Trials Trials Treatment 52

The Pharma Data

MARCH 17, 2022

Merck has an extensive clinical development program in lung cancer and is advancing multiple registration-enabling studies, with research directed at earlier stages of disease and novel combinations. Key studies in earlier stages of NSCLC include KEYNOTE-091, KEYNOTE-671, KEYNOTE-867 and KEYLYNK-012. About ETOP.

Therapies 52

Therapies Clinical Trials Disease Treatment 52